P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma

Authors :: Michelle S. Ginsberg
Maria E. Arcila
Caroline G. McCarthy
Alex Makhnin
Mark G. Kris
Gregory J Riely
Robin Guo
Romel Somwar
A. Drilon
M. Ladanyi
Adam J. Schoenfeld
Natasha Rekhtman
Lukas Delasos
Andrew J. Plodkowski
Isabel Ruth Preeshagul
Monika A. Davare
Source :: Journal of Thoracic Oncology. 14:S574-S575
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Pulmonary and Respiratory Medicine
Lung
Cabozantinib
business.industry
medicine.disease
chemistry.chemical_compound
medicine.anatomical_structure
Oncology
chemistry
Phase (matter)
ROS1
medicine
Cancer research
Adenocarcinoma
business

Full Text Access

Tools